This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit ManagedCareCGM.com

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Navigation
Search
Generic filters

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D 

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM


Watch Now

Effective September 28, 2021, Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) systems are covered by Manitoba Pharmacare for eligible clients 25 years old and younger

Effective September 28, 2021, Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) systems are covered by Manitoba Pharmacare for eligible clients 25 years old and younger – Province of Manitoba – September 28, 2021

Read More

Lower A1c and Reduce Hospital/ED Use in Members with Insulin-Treated Type 2 Diabetes via Real-Time Continuous Glucose Monitoring

Lower A1c and Reduce Hospital/ED Use in Members with Insulin-Treated Type 2 Diabetes via Real-Time Continuous Glucose Monitoring –  ManagedCareCGM.com – September 2021

Read More

FDA gives the go ahead for third-party developers to integrate real-time CGM data into their digital health apps and devices.

FDA gives the go ahead for third-party developers to integrate real-time CGM data into their digital health apps and devices. – Business Wire – July 2021

Read More

Footer Content

Provided by

This website is supported by an educational grant from Dexcom, Inc.